SOCS Serves is a dual-armed service initiative designed to create meaningful impact along the dermatology pathway and within communities.
Through structured programming and standardized toolkits, SOCS members can lead initiatives that:
Inspire students to pursue careers in medicine and dermatology
Increase dermatologic literacy in underserved communities
Address health disparities affecting skin of color
Strengthen SOCS’ impact across the globe
(Year 1: Mentorship Committee Lead)
SOCS Serves the Pathway introduces students—from K–12 through medical school—to careers in dermatology and healthcare.
By providing early exposure, mentorship, and educational programming, members help build a more diverse, informed, and representative future physician workforce.
Focus Areas:
Classroom presentations and career panels
Hands-on exposure to dermatology concepts
Mentorship connections and pathway guidance
Supporting underrepresented and underserved students
(Year 1: Public Education Committee Lead)
SOCS Serves the Community delivers culturally relevant dermatologic education to minority and underserved populations.
Through outreach events, partnerships, and public education efforts, members provide essential skin health guidance that improves awareness, prevention, and care.
Focus Areas:
Community health fairs and educational workshops
Public awareness campaigns on conditions affecting skin of color
Distribution of educational materials and referral resources
Collaboration with community-based organizations

Introducing the SOCS Global Council!
We proudly announce the SOCS Global Council, a strategic initiative that unifies leaders from international dermatology organizations who share a mission to advance skin of color dermatology.
Global Council Calendar of Events
Click the event to learn more:
|
13 Mar 2026
12:00 AM
International Master Course on Aging Science (IMCAS) Americas |
|
02 Apr 2026
12:00 AM
Dubai Derma |
|
30 Apr 2026
12:00 AM
International Pigment Cell Conference (IPCC) |
|
16 May 2026
12:00 AM
Australasian College of Dermatologists (ACD) Annual Scientific Meeting |
|
30 Sep 2026
12:00 AM
European Academy of Dermatology and Venereology (EADV) Congress 2026 |
The Global Council aims to:






Thank you to Novartis for supporting this initiative!

Help offset membership fees for colleagues in developing and resource-limited countries
Thank you for considering a donation to the SOCS Foundation. Your contribution is a direct investment in the SOCS mission, which is to promote awareness of and excellence within skin of color dermatology through research, education, mentorship and advocacy.
As we work to expand the work of SOCS globally, we are committed to bringing in colleagues from around to world to join our work to advance skin of color dermatology to achieve health equity and excellence in patient care worldwide.
Your support of the Global Access Membership Fund helps cover the cost of our international colleagues' membership in nations where resources are scarce. This support allows them to benefit from belonging to our Society so that they can take the knowledge, insights, and experiences gained from SOCS back to their communities.
Together, we can expand the reach and impact of the vital work of SOCS and advance patient care around the world.

SOCS Clinical Investigator Training Committee Co-Chairs Drs. Leandra A. Barnes (left) and Tarannum Jaleel.
For this month’s Committee Corner, we are delighted to highlight the SOCS Clinical Investigator Training Committee, co-chaired by Drs. Leandra A. Barnes and Tarannum Jaleel. This important and innovative committee is engaged in fostering a more inclusive and diverse community of clinical researchers within dermatology.
Collaborating closely with the National Medical Association (NMA) Dermatology Section, the committee focuses on creating resources and mentorship opportunities to develop the skills of future dermatology investigators and offering support to physicians interested in skin of color dermatology, health equity, and excellence in patient care.
The committee oversees the Clinical Investigator Training Mentorship Program, as well as developing the curriculum and agenda for the in-person full-day training conducted on the Friday before the start of the Annual Convention and Scientific Assembly of the NMA.
Main Achievements
The Clinical Investigator Training Mentorship Program has made significant strides in developing new clinical investigators in dermatology at both academic institutions and community clinics, focusing on serving underserved populations.
Since its inception, the program has successfully trained two cohorts of board-certified dermatologists and is partway through training a third cohort, equipping them with the essential skills to initiate and maintain clinical research. This initiative has not only enhanced the career trajectories of participating mentees but has also expanded the network of dermatologists engaged in clinical trials. Consequently, it has promoted access to clinical trials for diverse populations. By addressing barriers such as knowledge gaps, lack of training, and trial selection challenges that new investigators face who want to make clinical trials accessible to their patient populations, the Clinical Investigator Training Mentorship Program program has fostered a supportive environment for physicians dedicated to serving underrepresented groups, paving the way for more inclusive clinical trials that better reflect the diverse patient populations they serve.
Additionally, this program has received positive feedback from participants who have expressed how the mentorship has significantly impacted their confidence and ability to contribute to clinical research.
According to Drs. Barnes and Jaleel, “We continue to seek new opportunities and partnerships to further enhance the impact of the Clinical Investigator Training Mentorship Program program, ensuring that dermatology research becomes even more inclusive and representative. As we move forward, we are committed to expanding our outreach and collaboration efforts, aiming to create a sustainable model that can be replicated in other specialties and institutions, thereby broadening the scope and impact of our mentorship program even further.”
Meet the Co-Chairs
Leandra A. Barnes, MD, FAAD is Instructor of Dermatology, Founding Director of the Stanford Medicine Skin of Color Program, and Co-Director of the Hidradenitis Suppurativa Specialty Clinic atStanford Medicine Department of Dermatology. She comments, “As a physician-scientist deeply committed to advancing health equity and expanding opportunities for early investigators, co-chairing the Clinical Investigator Training Mentorship Program Mentoring Program has been incredibly personal and fulfilling. I am inspired by the generosity of our mentors and industry sponsors, the growth of our mentees, and the community we are fostering with NMA Dermatology and the Skin of Color Society. I look forward to seeing the lasting impact we will make in dermatologic research and beyond.”
Tarannum Jaleel, MD, MHSc is Assistant Professor, Duke Department of Dermatology, and Director, Duke Hidradenitis Suppurativa Medical and Procedural Clinic. She shares, "Seeing this program evolve over the past 3 years to enhance our clinical trial training program has been very fulfilling for me as a co-chair. The networking opportunities, longitudinal mentorship opportunities, as well as industry stakeholder involvement from the start, set this program apart and is highly empowering. The dedication and collaboration of all involved have truly made a significant impact on our clinical research community. As we continue to progress, I am excited to see the future advancements and the lasting influence this program will have on the field of clinical research."
A Message from the Co-Chairs
The co-chairs jointly invite stakeholders across academia, private practice, and industry to join us in the mission to diversify clinical research.
They point out that “by investing in mentoring programs like the Clinical Investigator Training Mentorship Program, we can collectively dismantle barriers and create a more inclusive environment for investigators and participants. Together, we can build a future where clinical trials truly represent the diverse populations they aim to serve. Supporting training programs to empower individuals earlier in medical school education and residency is critical to have representative populations in trials. We hope we can continue to partner with experienced investigators, program trainees, and industry partners over the years to come to grow the community dedicated to this. By fostering a more inclusive research community, we can ensure that the findings and treatments generated from clinical trials are applicable and beneficial to everyone, ultimately leading to improved health outcomes for all. Our commitment to inclusivity is not just a goal but a necessary journey we must embark on together, striving for a future where every individual has equal access to the benefits of medical research and advancements.”